Many CMT1B causing mutations activate the UPR and may be susceptible to therapeutic efforts to facilitate UPR function.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: